Batch report — flagship
RETP002
Flagship Retatrutide 30mg Pen — 300 clicks at 0.1 mg per click. Janoshik Analytical tested batch RETP002 on 4 November 2025 at 99.262% HPLC purity. The original PDF is hosted on remypeptides.com.
For in-vitro laboratory research only. Not for human or veterinary use.
Batch facts
- Product
- Retatrutide 30mg Pen — 300 clicks at 0.1 mg/click
- Batch number
RETP002- Molecule
- Retatrutide (LY-3437943) — CAS 2381089-83-2
- Purity (HPLC)
- 99.262%
- Test method
- HPLC (High-Performance Liquid Chromatography)
- Laboratory
- Janoshik Analytical
- Analysis date
- 4 November 2025
Janoshik report
The original Janoshik COA for the flagship 30mg pen release. Image and PDF are mirrored from Janoshik on remypeptides.com.
Common questions
What is batch RETP002?
The flagship Retatrutide 30mg Pen release. Janoshik Analytical tested it 4 November 2025 at 99.262% HPLC purity.
Which product ships with batch RETP002?
The flagship Retatrutide 30mg Pen — 300 clicks at 0.1 mg per click. Listed at remypeptides.com/remedium.
Where is the original Janoshik report?
The full PDF is at /janoshik-analytical-coa.pdf and the image at /remediumtestresults.webp. Both are mirrored from the Janoshik original.
Source the 30mg pen from Remy Peptides
The flagship Retatrutide 30mg Pen — 300 clicks at 0.1 mg per click — ships under batch RETP002.